328 related articles for article (PubMed ID: 19147588)
1. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.
Scharer CD; McCabe CD; Ali-Seyed M; Berger MF; Bulyk ML; Moreno CS
Cancer Res; 2009 Jan; 69(2):709-17. PubMed ID: 19147588
[TBL] [Abstract][Full Text] [Related]
2. SOX4 interacts with plakoglobin in a Wnt3a-dependent manner in prostate cancer cells.
Lai YH; Cheng J; Cheng D; Feasel ME; Beste KD; Peng J; Nusrat A; Moreno CS
BMC Cell Biol; 2011 Nov; 12():50. PubMed ID: 22098624
[TBL] [Abstract][Full Text] [Related]
3. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
4. The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.
Liu H; Wu Z; Zhou H; Cai W; Li X; Hu J; Gao L; Feng T; Wang L; Peng X; Qi M; Liu L; Han B
Neoplasia; 2019 Aug; 21(8):765-776. PubMed ID: 31238254
[TBL] [Abstract][Full Text] [Related]
5. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
6. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
8. The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.
Moreno CS
Am J Pathol; 2010 Feb; 176(2):518-27. PubMed ID: 20019190
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
10. Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis.
Vervoort SJ; de Jong OG; Roukens MG; Frederiks CL; Vermeulen JF; Lourenço AR; Bella L; Vidakovic AT; Sandoval JL; Moelans C; van Amersfoort M; Dallman MJ; Bruna A; Caldas C; Nieuwenhuis E; van der Wall E; Derksen P; van Diest P; Verhaar MC; Lam EW; Mokry M; Coffer PJ
Elife; 2018 Dec; 7():. PubMed ID: 30507376
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.
Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW
Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325
[TBL] [Abstract][Full Text] [Related]
12. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.
Wang L; Zhang J; Yang X; Chang YW; Qi M; Zhou Z; Zhang J; Han B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):301-7. PubMed ID: 23917306
[TBL] [Abstract][Full Text] [Related]
13. SOX4 is activated by C-MYC in prostate cancer.
Dong H; Hu J; Wang L; Qi M; Lu N; Tan X; Yang M; Bai X; Zhan X; Han B
Med Oncol; 2019 Sep; 36(11):92. PubMed ID: 31560094
[TBL] [Abstract][Full Text] [Related]
14. LINC00992 exerts oncogenic activities in prostate cancer via regulation of SOX4.
Fu C; Xin J; Zhang W; Lai J; Huang Z
Exp Cell Res; 2021 Nov; 408(1):112855. PubMed ID: 34599930
[TBL] [Abstract][Full Text] [Related]
15. Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis Through miR-3546/SOX4/Survivin Axis in Rat Thy-1 Nephritis.
Yao C; He F; Liu L; Zhang Z; Zhao C; Qiu W; Zhao D; Zhang J; Xie M; Gong Y; Yu T; Xia L; Qian B; Wang Y
Cell Physiol Biochem; 2018; 49(5):1898-1917. PubMed ID: 30235450
[TBL] [Abstract][Full Text] [Related]
16. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization.
Aaboe M; Birkenkamp-Demtroder K; Wiuf C; Sørensen FB; Thykjaer T; Sauter G; Jensen KM; Dyrskjøt L; Ørntoft T
Cancer Res; 2006 Apr; 66(7):3434-42. PubMed ID: 16585165
[TBL] [Abstract][Full Text] [Related]
17. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-140 inhibits proliferation and promotes apoptosis and cell cycle arrest of prostate cancer via degrading SOX4.
Liu Y; Li F; Lai D; Xie Q; Yin Y; Yang M; Su Z
J BUON; 2019; 24(1):249-255. PubMed ID: 30941977
[TBL] [Abstract][Full Text] [Related]
19. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.
Liu P; Ramachandran S; Ali Seyed M; Scharer CD; Laycock N; Dalton WB; Williams H; Karanam S; Datta MW; Jaye DL; Moreno CS
Cancer Res; 2006 Apr; 66(8):4011-9. PubMed ID: 16618720
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-19a-3p suppresses invasion and metastasis of prostate cancer via inhibiting SOX4.
Feng YG; Zhao JF; Xiao L; Rao WY; Ran C; Xiao YH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6245-6251. PubMed ID: 30338791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
